We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
AMSF Stock Check: Strong Balance Sheet, But is Earnings Slowing?
Read MoreHide Full Article
Key Takeaways
AMERISAFE is supported by rising voluntary premiums, strong retention and disciplined underwriting.
AMSF remains debt-free with $796.8M in cash and investments as of Dec. 31, 2025.
Free cash flow plunged 20.3% in 2024 and 61.8% in 2025, with EPS likely to decline in 2026.
AMERISAFE, Inc. (AMSF - Free Report) is positioned for steady growth, supported by rising voluntary premiums, solid customer retention and a strong underwriting profile. With a market cap of $632.1 million, the company remains a leading specialty provider of workers’ compensation insurance, focusing on small to mid-sized employers operating in hazardous industries.
AMSF’s niche approach gives it a clear edge. It serves industries such as trucking, construction, logging, agriculture and maritime, where risk selection and pricing discipline matter most. The business also benefits from the long lag between premium collection and claim payments, which allows AMERISAFE to invest premium dollars for extended periods and generate compounded returns.
Courtesy of solid prospects, this Zacks Rank #3 (Hold) stock is worth holding on to at the moment.
Profitability remains a key strength. AMSF’s return on equity stands at 15.9%, above the industry average of 14.3%, highlighting its ability to consistently generate value from its capital base. The company also maintains a conservative financial profile. It operates with minimal leverage and continues to carry a debt-free balance sheet, giving it flexibility to manage claims cycles and changing market conditions.
As of Dec. 31, 2025, AMERISAFE held $796.8 million in investments and cash, well above required capital levels. This balance sheet strength has enabled shareholder-friendly actions. The company repurchased $5.1 million of stock in 2024 and stepped that up to $12.1 million in 2025. Its dividend yield of 4.9% is also well above the industry average of 2%, making the stock attractive for income-focused investors.
Key Concerns
There are a few factors that investors should keep an eye on. Product concentration in workers’ compensation coverage, along with weakening free cash flow, remains a concern. Free cash flow fell 20.3% in 2024 and dropped another 61.8% in 2025. Net investment income has also been soft, which could limit earnings momentum.
The Zacks Consensus Estimate for AMERISAFE’s 2026 earnings is pegged at $2.13 per share, indicating a 2.7% year-over-year decline. The 2027 EPS estimate signals a further 2.4% fall. However, revenues for 2026 and 2027 are estimated to grow 9.1% and 5.7%, respectively.
The company beat earnings estimates in one of the last four quarters, met once and missed twice, the average surprise being negative 3.1%.
The Zacks Consensus Estimate for Accelerant’s current year bottom line is pegged at 68 cents per share, which witnessed four upward estimate revisions and no downward movement over the past month. Zacks estimate for ARX’s current-year revenues signals 15.4% year-over-year growth.
The Zacks Consensus Estimate for Reinsurance Group of America’s 2026 bottom line is pegged at $26.34 per share, indicating 15.9% year-over-year growth. The consensus mark for RGA’s current-year revenues predicts a 11.1% increase from a year ago.
The Zacks Consensus Estimate for Sun Life Financial’s current-year earnings signals a 7.9% improvement from a year ago. SLF beat earnings estimates in three of the past four quarters and met once, with the average surprise being 3.1%.
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report
predicting the 7 stocks that will soar highest in the coming month.
View the Zacks #1 Rank List
Image: Bigstock
AMSF Stock Check: Strong Balance Sheet, But is Earnings Slowing?
Key Takeaways
AMERISAFE, Inc. (AMSF - Free Report) is positioned for steady growth, supported by rising voluntary premiums, solid customer retention and a strong underwriting profile. With a market cap of $632.1 million, the company remains a leading specialty provider of workers’ compensation insurance, focusing on small to mid-sized employers operating in hazardous industries.
AMSF’s niche approach gives it a clear edge. It serves industries such as trucking, construction, logging, agriculture and maritime, where risk selection and pricing discipline matter most. The business also benefits from the long lag between premium collection and claim payments, which allows AMERISAFE to invest premium dollars for extended periods and generate compounded returns.
Courtesy of solid prospects, this Zacks Rank #3 (Hold) stock is worth holding on to at the moment.
Profitability remains a key strength. AMSF’s return on equity stands at 15.9%, above the industry average of 14.3%, highlighting its ability to consistently generate value from its capital base. The company also maintains a conservative financial profile. It operates with minimal leverage and continues to carry a debt-free balance sheet, giving it flexibility to manage claims cycles and changing market conditions.
As of Dec. 31, 2025, AMERISAFE held $796.8 million in investments and cash, well above required capital levels. This balance sheet strength has enabled shareholder-friendly actions. The company repurchased $5.1 million of stock in 2024 and stepped that up to $12.1 million in 2025. Its dividend yield of 4.9% is also well above the industry average of 2%, making the stock attractive for income-focused investors.
Key Concerns
There are a few factors that investors should keep an eye on. Product concentration in workers’ compensation coverage, along with weakening free cash flow, remains a concern. Free cash flow fell 20.3% in 2024 and dropped another 61.8% in 2025. Net investment income has also been soft, which could limit earnings momentum.
The Zacks Consensus Estimate for AMERISAFE’s 2026 earnings is pegged at $2.13 per share, indicating a 2.7% year-over-year decline. The 2027 EPS estimate signals a further 2.4% fall. However, revenues for 2026 and 2027 are estimated to grow 9.1% and 5.7%, respectively.
The company beat earnings estimates in one of the last four quarters, met once and missed twice, the average surprise being negative 3.1%.
AMERISAFE, Inc. Price, Consensus and EPS Surprise
AMERISAFE, Inc. price-consensus-eps-surprise-chart | AMERISAFE, Inc. Quote
Key Picks
Some better-ranked stocks in the broader insurance space are Accelerant Holdings (ARX - Free Report) , Reinsurance Group of America, Incorporated (RGA - Free Report) and Sun Life Financial Inc. (SLF - Free Report) , each carrying a Zacks Rank #2 (Buy) at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
The Zacks Consensus Estimate for Accelerant’s current year bottom line is pegged at 68 cents per share, which witnessed four upward estimate revisions and no downward movement over the past month. Zacks estimate for ARX’s current-year revenues signals 15.4% year-over-year growth.
The Zacks Consensus Estimate for Reinsurance Group of America’s 2026 bottom line is pegged at $26.34 per share, indicating 15.9% year-over-year growth. The consensus mark for RGA’s current-year revenues predicts a 11.1% increase from a year ago.
The Zacks Consensus Estimate for Sun Life Financial’s current-year earnings signals a 7.9% improvement from a year ago. SLF beat earnings estimates in three of the past four quarters and met once, with the average surprise being 3.1%.